Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
Though these drugs were originally developed for managing blood sugar in people with type 2 diabetes, researchers soon ...
Inability to get needed mental health care is a reality facing many people in this country, according to The State of Mental ...
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...